Advertisements



Inovio"s Manufacturing, Scalability Concerns Of Coronavirus Vaccine Keeps This Analyst On The Sidelines

Inovio Pharmaceuticals Inc (NASDAQ: INO) reported Tuesday interim Phase 1 readout for INO-4800, its DNA vaccine candidate against the novel coronaviru Lat.....»»

Category: blogSource: benzingaJun 30th, 2020

Benchmark analyst expects FDA to allow Inovio"s coronavirus vaccine to move to Phase 2/3 clinical

A Benchmark Research analyst expects that the Food and Drug Administration will allow Inovio Pharmaceuticals Inc.'s COVID-19 vaccine candidate to move to a Phase 2/3 study. Benchmark's Aydin Huseynov noted that while the Phase 1 efficacy data.....»»

Category: topSource: marketwatchJun 30th, 2020

Inovio Analysts Tackle Coronavirus Vaccine Timeline, Funding, Pipeline After Q1 Report

Despite Inovio Pharmaceuticals Inc's (NASDAQ: INO) first-quarter miss Monday, the sell-side remains largely upbeat on company, which is developing a coronavirus vaccine candidate.  The Inovio Analysts Stifel analyst S.....»»

Category: earningsSource: benzingaMay 12th, 2020

Applied DNA Analyst Says Coronavirus Testing, Vaccine Work Could Drive Major Upside

Shares of Applied DNA Sciences Inc (NASDAQ: APDN), which is in the race to develop a vaccine for the novel coronavirus, offer an attractiv La.....»»

Category: blogSource: benzinga21 hr. 16 min. ago

Analyst says sell Inovio on "unimpressive" COVID vaccine data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 1st, 2020

Inovio Plunges On Interim Phase 1 Coronavirus Data; DNA Vaccine Shows 94% Response Rate

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were moving to the downside Tuesday after the vaccine maker released interim Phase 1 data for the study that is evaluating its DNA vaccine read more.....»»

Category: blogSource: benzingaJun 30th, 2020

Inovio announces interim clinical data of INO-4800 coronavirus vaccine candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

Inovio Analyst Downgrades COVID-19 Vaccine Developer, Says Risk Higher After Rally

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares have rallied strongly in late June, moving from $14.27 on June 19 to $31.25 on July 25, translating to a stellar gain of about 110%. Lat.....»»

Category: blogSource: benzingaJun 29th, 2020

Moderna, Catalent Collaborate On Coronavirus Vaccine Manufacturing Capacity

Moderna Inc (NASDAQ: MRNA), a frontrunner in the COVID-19 vaccine race, announced a manufacturing collaboration agreement Thursday with contract development and m read more.....»»

Category: blogSource: benzingaJun 25th, 2020

Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed

Inovio Pharmaceuticals Inc. has yet to share results from the Phase 1 trial for its COVID-19 vaccine candidate, but has already received millions of dollars in funding to scale up manufacturing capacity......»»

Category: topSource: marketwatchJun 25th, 2020

Inovio gets $71M grant to scale up delivery device for potential Covid-19 vaccine

Inovio said Tuesday it has received $71 million from the Department of Defense to support the scale-up manufacturing of the device used to deliver its experimental Covid-19 vaccine candidate. The Plymouth Meeting company also said it plans to r.....»»

Category: topSource: bizjournalsJun 23rd, 2020

Inovio Faces Shareholder Lawsuit Over 3-Hour Coronavirus Vaccine Claim, Company Says DNA Medicine Misunderstood

Inovio Pharmaceuticals Inc (NASDAQ: INO) shareholders are suing the company in U.S. District Court alleging the vaccine maker misled investors by saying it came up with a coronavirus vaccine candidate in about three hours. read more.....»»

Category: blogSource: benzingaJun 16th, 2020

Novavax buys Czech manufacturing plant to boost production of coronavirus vaccine candidate

Gaithersburg biotech Novavax Inc. (NASDAQ: NVAX) said Wednesday it has acquired Praha Vaccines, including its manufacturing facility in the Czech Republic, in a bid meet the production goals for its coronavirus vaccine candidate. Novavax said t.....»»

Category: topSource: bizjournalsMay 28th, 2020

Moderna rally loses steam over COVID-19 vaccine worries

Shares of biotechs racing to make coronavirus vaccines, including Moderna Inc , fell about 10% on Wednesday, as investor concerns grew about the prospects of the experimental products that are still in early stages of development......»»

Category: topSource: reutersMay 27th, 2020

Moderna Analyst Says Biotech Has "First-To-Market" Potential For Coronavirus Vaccine

Moderna Inc (NASDAQ: MRNA) shares were trading at new highs Monday following the release of positive interim Phase 1 immunogenicity and safety .....»»

Category: blogSource: benzingaMay 18th, 2020

Sorrento Therapeutics Analyst Says Coronavirus Antibody Cocktail One Of Few Non-Vaccine Options

Sorrento Therapeutics Inc (NASDAQ: SRNE) shares spiked 158% Friday after the company disclosed that it has identified an antibody that demonstrate Latest Ratings.....»»

Category: blogSource: benzingaMay 18th, 2020

These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley

With about eight coronavirus vaccine candidates in clinical trials and 110 more in clinical testing, the race to a commercial product is intensifying. Against this backdrop, an analyst at Morgan Stanley looked at the most promising programs......»»

Category: blogSource: benzingaMay 18th, 2020

Asian stocks set to slip on coronavirus fears, vaccine timing

Asian equities were set to pull back on Wednesday as heightened concerns about coronavirus infections and the timing for a vaccine outweighed the lift from rebounding oil prices and upbeat corporate earnings in Europe......»»

Category: topSource: reutersMay 12th, 2020

Inovio Analysts Tackle Coronavirus Vaccine Timeline, Funding, Pipeline After Q1 Report

Despite Inovio Pharmaceuticals Inc's (NASDAQ: INO) first-quarter miss Monday, the sell-side remains largely upbeat on company, which is developing a corona.....»»

Category: blogSource: benzingaMay 12th, 2020

Inovio Q1 Results Miss Estimates, Coronavirus Vaccine Program On Track

Inovio Pharmaceuticals Inc (NASDAQ: INO), one of the frontrunners among companies developing vaccines for th.....»»

Category: earningsSource: benzingaMay 11th, 2020

Inovio Q1 Results Miss Estimates, Coronavirus Vaccine Program On Track

Inovio Pharmaceuticals Inc (NASDAQ: INO), one of the frontrunners among companies developing vaccines for the coronavirus, reported Monday after the close with first-q read more.....»»

Category: blogSource: benzingaMay 11th, 2020